JP2023503331A5 - - Google Patents

Info

Publication number
JP2023503331A5
JP2023503331A5 JP2022530212A JP2022530212A JP2023503331A5 JP 2023503331 A5 JP2023503331 A5 JP 2023503331A5 JP 2022530212 A JP2022530212 A JP 2022530212A JP 2022530212 A JP2022530212 A JP 2022530212A JP 2023503331 A5 JP2023503331 A5 JP 2023503331A5
Authority
JP
Japan
Prior art keywords
alkyl
dimethylocta
dien
diol
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022530212A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023503331A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/051609 external-priority patent/WO2021102569A1/en
Publication of JP2023503331A publication Critical patent/JP2023503331A/ja
Publication of JP2023503331A5 publication Critical patent/JP2023503331A5/ja
Pending legal-status Critical Current

Links

JP2022530212A 2019-11-26 2020-11-25 カンナビノイド誘導体 Pending JP2023503331A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962940568P 2019-11-26 2019-11-26
US62/940,568 2019-11-26
US202063076742P 2020-09-10 2020-09-10
US63/076,742 2020-09-10
US202063104927P 2020-10-23 2020-10-23
US63/104,927 2020-10-23
PCT/CA2020/051609 WO2021102569A1 (en) 2019-11-26 2020-11-25 Cannabinoid derivatives

Publications (2)

Publication Number Publication Date
JP2023503331A JP2023503331A (ja) 2023-01-27
JP2023503331A5 true JP2023503331A5 (enExample) 2023-11-22

Family

ID=76128641

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022530212A Pending JP2023503331A (ja) 2019-11-26 2020-11-25 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US20230122510A1 (enExample)
EP (1) EP4065568A4 (enExample)
JP (1) JP2023503331A (enExample)
WO (1) WO2021102569A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
US12252503B2 (en) 2019-07-12 2025-03-18 Canopy Growth Corporation Cannabinoid derivatives
JP2022551066A (ja) 2019-10-02 2022-12-07 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021102567A1 (en) 2019-11-26 2021-06-03 Canopy Growth Corporation Cannabigerol derivatives and use thereof as cannabinoid receptor modulators
US12240813B2 (en) 2020-05-19 2025-03-04 Cybin Irl Limited Deuterated tryptamine derivatives and methods of use
WO2021245672A1 (en) * 2020-06-03 2021-12-09 Epm (Ip), Inc. Cannabigerolic acid (cbga) derivatives and uses thereof

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2744882A (en) * 1949-01-26 1956-05-08 Union Carbide & Carbon Corp Unsymmetrical diphenylol methanes
US6737439B2 (en) * 2001-08-07 2004-05-18 The Board Of Trustees Of The University Of Illinois Aromatase inhibitors from Broussonetia papyrifera
WO2007139887A2 (en) * 2006-05-22 2007-12-06 Cargill, Incorporated Methods for treating bone or joint inflammation
GB2450493A (en) * 2007-06-25 2008-12-31 Gw Pharma Ltd Cannabigerol for use in treatment of diseases benefiting from agonism of CB1 and CB2 cannabinoid receptors
JP2011140477A (ja) 2009-03-04 2011-07-21 Tohoku Univ Ｃｂ１受容体アゴニスト
US9095598B2 (en) 2010-12-28 2015-08-04 The Board Of Trustees Of The University Of Arkansas Stilbenoid derivatives and their uses
PL223441B1 (pl) * 2013-09-27 2016-10-31 Univ Przyrodniczy We Wrocławiu 4'-O-β-D-glukopiranozylo-4,2'-dihydroksy-6'-metoksy-3'-prenylo-α,β-dihydrochalkon oraz sposób jego wytwarzania
WO2017175064A1 (en) * 2016-04-04 2017-10-12 Full Spectrum Laboratories Ltd Bioenzymatic synthesis of tetrahydrocannabivarin (thc-v), cannabinol (cbn), and cannabivarin (cbv) and their use as therapeutic agents
WO2018112138A1 (en) 2016-12-15 2018-06-21 Anavi Goffer Sharon Treatment of mental, movement and behavioral disorders
CN107987047B (zh) * 2017-12-22 2020-03-20 成都普思生物科技股份有限公司 一种从桑白皮中提取的牻牛儿基黄酮化合物及其方法和应用
US20230286906A1 (en) * 2019-11-26 2023-09-14 Canopy Growth Corporation Cannabinoid derivatives

Similar Documents

Publication Publication Date Title
JP2023503331A5 (enExample)
JP2022540586A5 (enExample)
JP2022540433A5 (enExample)
JP2022540434A5 (enExample)
JP2022540432A5 (enExample)
JP2022539400A5 (enExample)
JP5815765B2 (ja) イソオキサゾール誘導体及び代謝型グルタミン酸受容体ポテンシエーターとしてのその使用
JP2023503601A5 (enExample)
EP2382212B1 (en) Substituted oxadiazole derivatives as s1p agonists in the treatment of autoimmune and inflammatory diseases
JP2022540585A5 (enExample)
JP5820056B2 (ja) Ｃｅｔｐ阻害剤としてのシクロアルケニルアリール誘導体
JP2022539401A5 (enExample)
BRPI0707427A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar dislipidemia, aterosclerose, e diabetes e complicações da mesma, para elevar os nìveis plásmicos de hdl, e para diminuir triglicerìdeos plásmicos, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo
AU2007292993A1 (en) Pyridin-4-yl derivatives as immunomodulating agents
JP2013509431A (ja) 三環式ヘテロ環化合物
CA2741839A1 (en) 1-oxa-8-azaspiro [4,5] decane-8-carboxamide compounds as faah inhibitors
JPWO2017209155A1 (ja) スルホンアミド化合物又はその塩
JP2009114185A (ja) Ｐｐａｒ活性化化合物及びこれを含有する医薬組成物
CZ287771B6 (en) Dihydrobenzopyran derivatives, process and intermediates for their preparation, their use and pharmaceutical preparations based thereon
JP2023503330A5 (enExample)
HRP20171099T1 (hr) Derivati pirolo[2,3-d]pirimidina kao agonisti cb2 receptora
JP2013513615A (ja) 脂肪酸アミドヒドロラーゼのアゾ環状阻害薬
EP2956135A1 (en) HETEROCYCLIC AMIDE DERIVATIVES AS P2X7 RECEPTOR ANTAGONISTS& xA;
JP2013514280A (ja) スフィンゴシン１−リン酸１（ｓ１ｐ１）受容体アゴニストとして使用するためのオキサジアゾール置換インダゾール誘導体
US20130237566A1 (en) Heterocyclic compounds as s1p1 agonists for the treatment of autoimmune and vascular diseases